Testosterone replacement therapy (TRT), which has come under scrutiny recently for a suspected link to cardiovascular disease, improves arterial endothelial function in some men when prescribed for symptomatic hypogonadism, Cleveland Clinic researchers have found.
Data from a study of 20 men treated for at least 3 months with topical TRT or TRT pellets for symptomatic hypogonadism revealed either no change or an improvement in reactive hyperemia index (RHI) and augmentation index (AI), measures of endothelial function and arterial stiffness, compared with pre-therapy, reported Daniel Shoskes, MD, at the American Urological Association’s 2016 annual meeting.
https://consultqd.clevelandclinic.o...terial-endothelial-function-men-hypogonadism/
Data from a study of 20 men treated for at least 3 months with topical TRT or TRT pellets for symptomatic hypogonadism revealed either no change or an improvement in reactive hyperemia index (RHI) and augmentation index (AI), measures of endothelial function and arterial stiffness, compared with pre-therapy, reported Daniel Shoskes, MD, at the American Urological Association’s 2016 annual meeting.
https://consultqd.clevelandclinic.o...terial-endothelial-function-men-hypogonadism/
Last edited by a moderator: